日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer

高血糖和 O-GlcNAc 转移酶活性驱动三阴性乳腺癌中的癌症干细胞通路

Saheed A Ayodeji, Bin Bao, Emily A Teslow, Lisa A Polin, Greg Dyson, Aliccia Bollig-Fischer, Charlie Fehl

Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancer

新型癌症基因SLITRK3在鳞状细胞肺癌中激活NTRK3的作用

Aliccia Bollig-Fischer ,Bin Bao ,Morenci Manning ,Greg Dyson ,Sharon K Michelhaugh ,Sandeep Mittal ,Gerold Bepler ,Hirva Mamdani

Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer

TET1 和 5hmC 在肥胖相关通路中的作用,该通路驱动三阴性乳腺癌中的癌症干细胞

Bin Bao #, Emily A Teslow #, Cristina Mitrea, Julie L Boerner, Greg Dyson, Aliccia Bollig-Fischer

Detecting qualitative changes in biological systems

检测生物系统中的质变

Mitrea, Cristina; Bollig-Fischer, Aliccia; Voichiţa, Călin; Donato, Michele; Romero, Roberto; Drăghici, Sorin

Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer Patients

对非洲裔美国非小细胞肺癌患者已知驱动基因和新基因的突变图谱进行分析

Lusk, Christine M; Watza, Donovan; Dyson, Greg; Craig, Douglas; Ratliff, Valerie; Wenzlaff, Angela S; Lonardo, Fulvio; Bollig-Fischer, Aliccia; Bepler, Gerold; Purrington, Kristen; Gadgeel, Shirish; Schwartz, Ann G

Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells

肥胖诱导的 MBD2_v2 表达促进肿瘤起始三阴性乳腺癌干细胞

Emily A Teslow, Cristina Mitrea, Bin Bao, Ramzi M Mohammad, Lisa A Polin, Greg Dyson, Kristen S Purrington, Aliccia Bollig-Fischer

Racial Disparities in the Molecular Landscape of Cancer

癌症分子图谱中的种族差异

Heath, Elisabeth I; Lynce, Filipa; Xiu, Joanne; Ellerbrock, Angela; Reddy, Sandeep K; Obeid, Elias; Liu, Stephen V; Bollig-Fischer, Aliccia; Separovic, Duska; Vanderwalde, Ari

Integrating 5hmC and gene expression data to infer regulatory mechanisms

整合 5hmC 和基因表达数据以推断调控机制

Mitrea, Cristina; Wijesinghe, Priyanga; Dyson, Greg; Kruger, Adéle; Ruden, Douglas M; Draghici, Sorin; Bollig-Fischer, Aliccia

Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity

使用厄洛替尼和特定抗氧化剂治疗三阴性乳腺癌细胞可通过靶向癌细胞异质性来克服耐药性

Bin Bao, Cristina Mitrea, Priyanga Wijesinghe, Luca Marchetti, Emily Girsch, Rebecca L Farr, Julie L Boerner, Ramzi Mohammad, Greg Dyson, Stanley R Terlecky, Aliccia Bollig-Fischer

Racial diversity of actionable mutations in non-small cell lung cancer

非小细胞肺癌中可靶向突变的种族多样性

Bollig-Fischer, Aliccia; Chen, Wei; Gadgeel, Shirish M; Wenzlaff, Angela S; Cote, Michele L; Schwartz, Ann G; Bepler, Gerold